Facebook Linkedin RSS Twitter Youtube
Home 2025

Intranasal administration

Iconovo and Lonza Agree to Collaborate on the Formulation Development of an Intranasal Biologic
Bioprocessing

Iconovo and Lonza Agree to Collaborate on the Formulation Development of an Intranasal Biologic

Alzheimer’s Disease Neurodegeneration Held Back in Mice Treated Using Enzyme Inhibiting Nasal Spray
Featured

Alzheimer’s Disease Neurodegeneration Held Back in Mice Treated Using Enzyme Inhibiting Nasal Spray

Flu Vaccine Strategy Pairs Injection and Nasal Spray, Shows Promise in Pigs
Drug Discovery

Flu Vaccine Strategy Pairs Injection and Nasal Spray, Shows Promise in Pigs

SARS-CoV-2 May Be Thwarted by Nasally Administered DARPins
Coronavirus

SARS-CoV-2 May Be Thwarted by Nasally Administered DARPins

Nasal Spray Research to Combat COVID-19 and Other Respiratory Infections Awarded Grant
Coronavirus

Nasal Spray Research to Combat COVID-19 and Other Respiratory Infections Awarded Grant

Nasal Vaccines May Offer Protection Against Different Viral Variants
Coronavirus

Nasal Vaccines May Offer Protection Against Different Viral Variants

Nose Drops with Engineered Bacteria Protect against Meningitis
Drug Discovery

Nose Drops with Engineered Bacteria Protect against Meningitis

Gene Therapy Pioneer, Regeneron Partner on Nasal Spray vs. COVID-19
Coronavirus

Gene Therapy Pioneer, Regeneron Partner on Nasal Spray vs. COVID-19

Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate Aimed at Fentanyl
Drug Discovery

Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate Aimed at Fentanyl

Emergent Wins $63M BARDA Contract for Cyanide Antidote Spray Device
Industry News

Emergent Wins $63M BARDA Contract for Cyanide Antidote Spray Device

123Page 1 of 3
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.